PH27511A - Selective adenosine receptor agents - Google Patents

Selective adenosine receptor agents

Info

Publication number
PH27511A
PH27511A PH42193A PH42193A PH27511A PH 27511 A PH27511 A PH 27511A PH 42193 A PH42193 A PH 42193A PH 42193 A PH42193 A PH 42193A PH 27511 A PH27511 A PH 27511A
Authority
PH
Philippines
Prior art keywords
adenosine receptor
selective adenosine
receptor agents
agents
selective
Prior art date
Application number
PH42193A
Other languages
English (en)
Inventor
Norton P Peet
Nelson L Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH27511A publication Critical patent/PH27511A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH42193A 1990-03-26 1991-03-22 Selective adenosine receptor agents PH27511A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (1)

Publication Number Publication Date
PH27511A true PH27511A (en) 1993-08-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
PH42193A PH27511A (en) 1990-03-26 1991-03-22 Selective adenosine receptor agents

Country Status (22)

Country Link
US (1) US5047534A (no)
EP (1) EP0449175B1 (no)
JP (1) JP3181305B2 (no)
KR (1) KR100195368B1 (no)
CN (1) CN1032815C (no)
AR (1) AR247887A1 (no)
AT (1) ATE156130T1 (no)
AU (1) AU632914B2 (no)
CA (1) CA2038747C (no)
DE (1) DE69127010T2 (no)
DK (1) DK0449175T3 (no)
ES (1) ES2107431T3 (no)
FI (1) FI98461C (no)
GR (1) GR3025135T3 (no)
HU (1) HU208824B (no)
IE (1) IE910982A1 (no)
IL (1) IL97656A (no)
NO (1) NO177591C (no)
NZ (1) NZ237484A (no)
PH (1) PH27511A (no)
PT (1) PT97133B (no)
ZA (1) ZA912038B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
WO1994001114A1 (en) * 1992-07-08 1994-01-20 Kyowa Hakko Kogyo Co., Ltd. Antidepressant
JPH08512281A (ja) * 1993-02-26 1996-12-24 メレル ダウ ファーマス−ティカルズ インコーポレイテッド アデノシンａ▲下１▼受容体拮抗剤としてのキサンチン誘導体類
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
CA2159989C (en) * 1993-05-06 1994-11-24 Norton P. Peet 8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
AU2004244906A1 (en) * 2003-06-10 2004-12-16 Kyowa Hakko Kirin Co., Ltd. A method of treating an anxiety disorder
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

Also Published As

Publication number Publication date
DE69127010D1 (de) 1997-09-04
AR247887A1 (es) 1995-04-28
IL97656A (en) 1996-06-18
DE69127010T2 (de) 1997-11-13
NZ237484A (en) 1993-10-26
FI911420A (fi) 1991-09-27
ATE156130T1 (de) 1997-08-15
ZA912038B (en) 1991-12-24
CA2038747A1 (en) 1991-09-27
KR910016752A (ko) 1991-11-05
CN1032815C (zh) 1996-09-18
CA2038747C (en) 2002-05-28
FI911420A0 (fi) 1991-03-25
NO911200L (no) 1991-09-27
IE910982A1 (en) 1991-10-09
EP0449175A2 (en) 1991-10-02
EP0449175A3 (en) 1993-01-20
CN1055181A (zh) 1991-10-09
FI98461C (fi) 1997-06-25
HUT56570A (en) 1991-09-30
JP3181305B2 (ja) 2001-07-03
ES2107431T3 (es) 1997-12-01
IL97656A0 (en) 1992-06-21
US5047534A (en) 1991-09-10
PT97133A (pt) 1991-12-31
GR3025135T3 (en) 1998-02-27
KR100195368B1 (ko) 1999-06-15
PT97133B (pt) 1998-07-31
NO177591B (no) 1995-07-10
EP0449175B1 (en) 1997-07-30
NO177591C (no) 1995-10-18
FI98461B (fi) 1997-03-14
NO911200D0 (no) 1991-03-25
HU208824B (en) 1994-01-28
DK0449175T3 (da) 1998-02-23
AU632914B2 (en) 1993-01-14
JPH04221384A (ja) 1992-08-11
AU7353791A (en) 1991-10-03

Similar Documents

Publication Publication Date Title
HU9300964D0 (en) Nucleoside derivatives
ZA89440B (en) Dideoxydidehydrocarbocyclic nucleosides
HU913074D0 (en) Fibrinogenic receptor antagonists
OA09677A (en) Nucleoside derivatives
IL88999A0 (en) Dideoxydidehydrocarbocyclic nucleosides
GB2264948B (en) Human adenosine receptors
ZA913721B (en) Antiviral agents
IL97486A0 (en) Neurospora expression system
EP0449175A3 (en) Selective adenosine receptor agents
OA09697A (en) Nucleoside derivatives
EP0497988A4 (en) Antiviral agent
GB9014194D0 (en) Antiparasitic agents
ZA902282B (en) Selective adenosine receptor compounds
GB9008202D0 (en) Cushion
IL106287A0 (en) Receptor derivatives
FI955257A0 (fi) 8-substituoidut-ksantiinit valikoivina adenosiinireseptoriaineina
EP0450102A4 (en) Nucleoside derivative
ZA934873B (en) Receptor derivatives
EP0442757A3 (en) Therapeutic nucleosides
GB9110987D0 (en) Dideoxydidehydrocarboxyclic nucleosides
EP0539587A4 (en) Antiretroviral agent
GB9017922D0 (en) Antiparasitic agents
GB9007566D0 (en) Nucleoside derivatives
GB9007651D0 (en) Nucleoside derivatives
GB9007650D0 (en) Nucleoside derivatives